On average, 7 out of 10 retail investors suffer losses when trading turbo certificates. Turbo certificates are highly risky products and are not suited for long-term investment strategies.
3.701 - 3.725 of 84.142
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Cigna Call 320,00 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 12,87x
- Analysis
- Cigna Call 260,00 15 Jan 2027
- Goldman Sachs
- 15.01.27
- 4,88x
- Analysis
- Nordex Put 44,00 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 4,06x
- Analysis
- Cigna Call 280,00 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 10,28x
- Analysis
- Alcoa Put 50,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 1,56x
- Analysis
- Ulta Beauty Call 480,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 2,91x
- Analysis
- Ballard Power Systems Call 3,00 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 4,42x
- Analysis
- Cigna Call 400,00 16 Oct 2026
- Goldman Sachs
- 16.10.26
- 9,28x
- Analysis
- URANIUM ENERGY Call 10,50 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 5,25x
- Analysis
- Alcoa Put 30,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 2,46x
- Analysis
- XYZ UN Put 40,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 2,01x
- Analysis
- Super Micro Computer Put 28,00 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 3,18x
- Analysis
- Alcoa Put 30,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,36x
- Analysis
- Cigna Put 300,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,03x
- Analysis
- Alcoa Put 30,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 1,70x
- Analysis
- Swiss Re Call 210,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 8,61x
- Analysis
- Comcast Call 28,00 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 13,00x
- Analysis
- EA (Electronic Arts) Put 140,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 17,78x
- Analysis
- Check Point Call 120,00 15 Jan 2027
- Goldman Sachs
- 15.01.27
- 3,99x
- Analysis
- Citigroup Call 120,00 20 Nov 2026
- Goldman Sachs
- 20.11.26
- 5,66x
- Analysis
- Accenture Put 160,00 16 Oct 2026
- Goldman Sachs
- 16.10.26
- 4,43x
- Analysis
- Cigna Put 300,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,65x
- Analysis
- Teva Pharmaceutical Industries Call 38,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,84x
- Analysis
- Check Point Call 180,00 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 10,85x
- Analysis
- Check Point Call 180,00 15 Jan 2027
- Goldman Sachs
- 15.01.27
- 6,41x
- Analysis